HC Q study #20
See all studies
4/27
Positive
Late treatment study
Sánchez-Álvarez et al., Nefrología, doi:10.1016/j.nefroe.2020.04.002 (Peer Reviewed)
Status of SARS-CoV-2 infection in patients on renal replacement therapy. Report of the COVID-19 Registry of the Spanish Society of Nephrology (SEN)
Analysis of 868 patients on renal replacement therapy. Statistically significant reduction in mortality with HC Q for patients on dialysis (OR 0.47, p=0.005).
No statistically significant change was found for transplant patients (the result is not given but likely the sample size is too small - the number of transplant patients was half the number of dialysis patients).
Source   Share   Tweet
See all studies
Please send us corrections, updates, or comments.
Submit